Markets

Return or reputation? Néstle and GSK cases show what really drives ESG action

Investors filed a resolution against Nestlé on healthy foods but have not taken interest in GSK’s involvement in the mother and baby crisis

Investors filed a resolution against Nestlé on healthy foods but have not taken interest in GSK’s involvement in mother and baby homes. Picture: NurPhoto

Investors have taken issue with Nestlé this week, urging it to provide healthier products as part of their responsible investing agenda.

It is markedly different approach taken by asset managers, who I reported earlier this week won’t be engaging with GlaxoSmithKline (GSK) over its lack of remediation for their involvement in trials at the mother and baby homes.

In an era of ESG, why do unhealthy foods take precedent over the treatment of humans and ...